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Abstract The thermogenic activity of brown adipose tissue
(BAT) is heavily dependent on high perfusion, through its dense
vascular system. Angiogenesis must go hand-in-hand with BAT
functions, but little is known about the factors controlling it. In
the present study we demonstrate that: (a) vascular endothelial
growth factor (VEGF) is synthesised and released in brown
adipocytes in culture; (b) VEGF mRNA isoforms and protein
appear in dispersed mature brown adipocytes and whole tissue;
(c) VEGF expression is increased in BAT from cold-exposed
rats, and in cultured brown adipocytes exposed to noradrenaline
and the L3-adrenoceptor agonists ; (e) BAT from genetically
obese (fa/fa) rats exhibits reduced expression of VEGF as well as
a change in the ratio of mRNA isoforms. It is concluded that
sympathetic control of VEGF expression via noradrenaline
acting on L3-adrenoceptors plays a major role in developmental
and adaptive angiogenesis, and defects in this contribute to the
reduced thermogenic capacity of BAT in genetic obesity.
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1. Introduction
Brown adipose tissue (BAT) is an important site of energy
expenditure, which is functionally quiescent in obesity [1].
Chronic exposure to cold, by increasing the sympathetic out-
put, induces the recruitment process of BAT [2], which con-
sists of a series of events that transiently transform a prolif-
eratively dormant into a hyperplastic organ. The mechanisms
by which brown fat atrophy is mediated in obesity are not
completely known, although we have recently reported that
tumour necrosis factor-K (TNF-K) induces apoptosis of
brown adipocytes and that noradrenaline counteracts it [3].
The thermogenic activity of brown fat requires a very high
perfusion rate, both for the supply of oxygen and substrate
and for the export of the heat and carbon dioxide produced.
BAT hyperplasia is accompanied by angiogenesis and results
from a rapid activation of mitosis in brown fat precursor cells
and endothelial cells forming the capillaries [4].
The process of new vessel generation from a preexisting
microvascular network implies the production of several an-
giogenic factors [5], but little is known about the mechanisms
of angiogenesis in BAT and their modulation by factors op-
erating during development and recruitment. Asano et al. [6]
have recently shown that vascular endothelial growth factor
(VEGF), one of the most potent angiogenic factors, is ex-
pressed abundantly in rat brown fat. VEGF is a dimeric 46
kDa protein that acts as a potent and speci¢c mitogen for
vascular endothelial cells and possesses a leader sequence
which allows it to be secreted [7]. In vitro and in vivo studies
established that VEGF acts as a mitogen for endothelial cells
[8], and as a promoter of endothelial cell migration [9]. Multi-
ple forms of VEGF mRNA, encoding peptides of di¡erent
lengths, are the result of alternative splicing of the gene prod-
uct [10]. The three major VEGF mRNA forms, which encode
proteins of 188, 164 and 120 amino acids, were observed in
various rat tissues [11]. VEGF 165/164 (human/rodent homo-
logue) is often assumed to be the predominant form, although
truly quantitative assessments are lacking [11]. The various
VEGF isoforms have strikingly di¡erent secretion patterns,
which suggest multiple physiological roles for this family of
polypeptides.
Given the limited understanding of factors a¡ecting BAT
angiogenesis, the aims of the present study were: (i) to inves-
tigate the expression of the VEGF isoforms in rat brown fat
cells di¡erentiated in culture; (ii) to analyse the in vitro and in
vivo noradrenergic modulation of their expression; (iii) to
verify any relevant changes in this molecular system in genet-
ically obese animals. We conclude that VEGF is synthesised
in and released from brown adipocytes, that its production
appears to be under the stimulatory control of noradrenaline,
mainly through L3-adrenoceptors, and that this noradrenergic
control is modi¢ed in genetically obese animals.
2. Materials and methods
2.1. Brown adipocytes isolation and cell culture treatment
Brown fat precursor cells were isolated from the interscapular
brown fat of male Sprague-Dawley rats (150^160 g body weight;
Harlan Nossan, Correzzana, Italy), as previously described [12,13].
Three million cells seeded in 6-well culture plates (Costar, Milan,
Italy) were cultured under a water-saturated atmosphere of 6% CO2 in
air at 37‡C in 2.0 ml of a culture medium consisting of Dulbecco’s
modi¢ed Eagle’s medium (DMEM) supplemented with 4 mM gluta-
mine, 10% newborn calf serum, 4 nM insulin, 4 nM triiodothyronine,
10 mM HEPES, and 50 IU of penicillin, 50 Wg of streptomycin, and
25 Wg of sodium ascorbate per ml (all from Sigma, Milan, Italy).
Di¡erent concentrations of the L3-adrenoceptor agonist SR58611A
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(N-[(2S)-7-carbethoxy-1,2,3,4-tetrahydronaphth-2-yl]-(2R)-2-hydroxy-
2-(3-chlorophenyl)ethanamine hydrochloride) (generous gift from L.
Manara, Sano¢ Winthrop, Milan, Italy) were added to cultured fat
cells at day 8 (i.e. at the time of con£uence and di¡erentiation) for 18
h for enzyme immunoassay (EIA) experiments. Noradrenaline (Sigma,
Milan, Italy) (1 WM) or SR58611A (1 WM) was added to cultured fat
cells at day 8 for 4 h for reverse transcriptase-polymerase chain re-
action (RT-PCR) experiments.
2.2. PCR assay
Total cytoplasmic RNA was isolated from 1U106 cultured cells or
from 20 mg of tissue using the RNazol method (TM Cinna Scienti¢c,
Friendswood, TX, USA). For PCR analysis, performed as previously
described [13], an aliquot (10% vol) of the cDNA was ampli¢ed using
the speci¢c primers for rat VEGF: 5P-CCA TGA ACT TTC TGC
TCT CTT G-3P (nucleotides 2^24) and 5P-GGT GAG AGG TCT
AGT TCC CGA-3P (nucleotides 610^630) [14] by Taq DNA polymer-
ase (Promega, Milan, Italy) in 25 Wl of standard bu¡er (10 mM Tris-
HCl, pH 9, 50 mM KCl, 0.1% Triton X-100, 2.5 mM MgCl2, and 200
WM dNTPs). After 35 cycles a ¢nal 10-min incubation at 72‡C was
carried out. Another aliquot (2% vol) of the same cDNA was ampli-
¢ed, using the speci¢c primers for rat L-actin [15], for 20 cycles to
normalise PCR VEGF results in obese animals and noradrenaline- or
SR58611A-treated cells. 10 Wl of each PCR reaction product was
separated by electrophoresis (2.0% agarose gel in Tris-acetate-EDTA
bu¡er, containing 0.1 mg/ml of ethidium bromide), revealed with a
QuickImage-D (Camberra Packard, Milan, Italy) and densitometri-
cally analysed with Phoretix 1D version 3.0. The speci¢city of PCR
products was con¢rmed by sequence analysis, performed by M Med-
ical (Florence, Italy).
2.3. VEGF immunoassay
The VEGF concentrations in the medium of cultured cells were
measured by means of Cytokit Red TM VEGF (Cyt Immune Sciences
Inc., College Park, MD, USA) using a polyclonal rabbit antibody that
recognises rat VEGF [16]. Medium of each well was collected and
concentrated by means of Centrisart I (Sartorius, Goºttingen, Ger-
many). EIA was performed according to the procedures suggested
by the manufacturer. The range of detection of this assay is 0.195^
200 ng/ml. The assay was performed in triplicate and the intra-assay
coe⁄cient of variation was þ 7.0%.
2.4. Western blotting
Western blotting was performed as previously described [13]. Ali-
quots corresponding to 50 Wg of protein were applied to 15% SDS-
polyacrylamide gels. Western blotting consisted of overnight electro-
blotting the proteins from the polyacrylamide gel onto nitrocellulose
¢lter paper, blocking with 3% non-fat dried milk (2 h at room temper-
ature), incubating the ¢lter at room temperature for 2 h with the
primary antibody (polyclonal rabbit antibody, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA) and for 1 h with secondary antibody
(alkaline phosphatase-conjugated anti-rabbit IgG, Boehringer Mann-
heim, Milan, Italy) at room temperature. As little as 15^25 ng of
VEGF protein can be detected by this method. The coe⁄cient of
variation between the di¡erent experiments was lower than 5%.
2.5. Immunohistochemistry
Genetically obese male Zucker rats (fa/fa) and their lean littermates
(+/fa), 6 weeks of age, were obtained from Harlan Nossan (Correzza-
na, Italy). Some rats were kept at room temperature (20^22‡C; re-
ferred to as control rats), some were acclimated at 4‡C for 2 weeks
(cold-acclimated rats) and some were treated (1 mg/kg/day) intraper-
itoneally with CL 316,243 (disodium R,R-5([2-[3-chlorophenyl]-2-hy-
droxy ethyl]-1,3-benzodioxole-2,2-dicarboxylate) (a generous gift from
Kurt Steiner, Wyeth-Ayerst, USA), a selective L3-adrenoceptor ago-
nist, for 2 days. The animals were anaesthetised with 0.36 M chloral
hydrate (400 mg/kg) and perfused intra-aortically with a 4% para-
formaldehyde solution in 0.1 M phosphate bu¡er (pH 7.4). Interscap-
ular brown adipose tissue was carefully dissected and immediately
post¢xed overnight at 4‡C in the same ¢xative, before being washed,
dehydrated in ethanol and embedded in para⁄n. Immunoreactivity
for VEGF was assessed in 3 Wm thick serial sections using the avidin-
biotin-peroxidase method (ABC method). Negative controls were ob-
tained in each instance by omitting the primary antibody and using
preimmune serum instead of the primary antiserum.
2.6. Data analysis
The comparisons were made using one-way ANOVA followed by
Student-Newman-Keuls post-hoc comparisons; P6 0.05 vs controls
was considered signi¢cant.
3. Results
Expression of VEGF mRNA was revealed by RT-PCR in
rat cultured precon£uent and con£uent cells (Fig. 1A). Two
VEGF mRNA isoforms were detected under our experimental
conditions: one of 628 bp and corresponding to the VEGF
164 isoform, and the other of 496 bp and corresponding to the
VEGF 120 isoform. In addition, both the rat precon£uent and
con£uent cells contained a protein species of approximately 23
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Fig. 1. RT-PCR and Western blot analysis of RNAs and proteins
isolated from precon£uent and con£uent brown adipocytes, mature
brown adipocytes and rat BAT. A: Ethidium bromide agarose gel
electrophoresis pictures of VEGF cDNA fragments ampli¢ed by
PCR from the various preparations; L, 100 bp DNA ladder (M
Medical, Florence, Italy). The PCR conditions were as follows: de-
naturation at 94‡C for 30 s, annealing at 56‡C for 1 min and poly-
merization at 72‡C for 1 min). B: Immunoblot obtained by separat-
ing 50 Wg of protein on 15% SDS-polyacrylamide gel under
reducing conditions.
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kDa, which cross-reacted with polyclonal anti-VEGF antibod-
ies (Fig. 1B). Both VEGF mRNA isoforms and protein ap-
peared to be present also in enzymatically dispersed rat ma-
ture brown fat cells and in rat BAT in toto (Fig. 1A,B). In the
latter two mRNA preparations a third isoform of 703 bp,
corresponding to the VEGF 188 isoform, was detected.
Since cold exposure, by inducing sympathetic noradrenergic
stimulation, activates BAT thermogenesis, VEGF mRNA ex-
pression was measured in BAT taken from animals exposed
either to a cold environment (4‡C for 4 h) or to room temper-
ature. The VEGF mRNA levels were signi¢cantly higher in
BAT of cold-exposed than room-temperature-acclimated ani-
mals (data not shown), con¢rming previously reported results
[6]. These results were also con¢rmed in vitro using noradren-
aline treatment (1 M for 4 h) to induce VEGF mRNA ex-
pression in cultured brown adipocytes (Fig. 2). To study the
role of the L3-adrenoceptor in this noradrenaline-mediated
e¡ect, the cultured brown fat cells were treated for 4 h with
1 M SR58611A, a selective L3-adrenoceptor agonist, and total
RNA was harvested for RT-PCR analysis. RT-PCR products
were run and the quantities of minor and major mRNA
VEGF isoforms of each sample were densitometrically ana-
lysed, their values were summated and normalised with L-ac-
tin values. Fig. 2 shows that SR58611A was able to increase
3-fold the VEGF mRNA expression. Neither noradrenaline
nor SR58611A was able to signi¢cantly change the L-actin
mRNA levels in cultured brown adipocytes over a wide con-
centration range (from 1 nM to 100 WM, data not shown).
SR58611A also dose-dependently increased VEGF concen-
trations in the medium of treated cells. Fig. 3 summarises the
results of EIA experiments showing that the VEGF concen-
trations are markedly increased in the medium of cultured
brown fat cells after 18 h treatment with di¡erent concentra-
tions of SR58611A, indicating that stimulation of L3-adreno-
ceptors not only increases the expression of VEGF, but also
causes its release.
Obesity is generally associated with a reduction in BAT
sympathetic nervous system activity, and hence with a rela-
tively quiescent, atrophied and poorly vascularised brown fat
[17]. To verify the VEGF expression in this condition, total
RNA, extracted from BAT of genetically obese fa/fa Zucker
rats and lean +/fa littermates, was used for RT-PCR. RT-
PCR products were run and the quantities of three mRNA
VEGF isoforms of each sample were densitometrically ana-
lysed, summated and normalised with L-actin values. Fig. 4
shows that total VEGF mRNA is decreased in obese animals.
In particular, the ratio between the shortest isoform and the
major one was decreased 2-fold in fa/fa rat compared to lean
controls, suggesting the possibility of a di¡erent modulation
of alternative splicing in obese animals.
In order to con¢rm the previous results and to identify the
cytotypes expressing VEGF in vivo, we evaluated the VEGF
FEBS 21372 13-1-99 Cyaan Magenta Geel Zwart
Fig. 3. E¡ect of various SR58611A concentrations on VEGF release
from brown fat cells in EIA experiments. Results represent the
mean þ S.E.M. of three di¡erent experiments, each performed in
triplicate.
Fig. 2. RT-PCR analysis of VEGF in con£uent cells treated with
noradrenaline (NA) or L3-adrenoceptors agonist (SR58611A).
Upper: Representative agarose gel showing the PCR analysis for
the VEGF and L-actin mRNA content; L, DNA ladder; CT, un-
treated cells. Lower: Densitometric analysis of RT-PCR experiments
is reported. The bars represent the mean values þ S.E.M. of three
separate experiments plotted in relation to the area under the curve
for the VEGF/L-actin ratio of control cells taken as one. *P6 0.05
vs control cells.
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immunoreactivity in rat interscapular BAT using the same
polyclonal antibody used for the in vitro and in vivo Western
blot evaluations. In control rats, the smooth muscle cells of
the extra- and intralobular arteries and veins and the endo-
thelial cells of capillaries were positive, while the brown adi-
pocytes were only weakly positive or, most frequently, com-
pletely negative (Fig. 5A). After 2 weeks of cold acclimation,
the immunoreactivity for VEGF increased both in the media
of the blood vessels and in the brown adipocytes (data not
shown). A very high degree of speci¢c cytoplasmic immuno-
staining was also noted in brown adipocytes of rats treated
with the L3-adrenoceptor agonist CL 316,243 for 2 days
(1 mg/kg/day), thus con¢rming the involvement of L3-adreno-
ceptors in the noradrenaline-induced increase of VEGF ex-
pression in brown adipocytes (Fig. 5B). In the genetically
obese (fa/fa) Zucker rats, the immunohistochemical expression
of VEGF appeared very low, both in the blood vessel and in
the brown adipocytes. No other cytotypes were found to be
positive for VEGF in the interscapular brown adipose tissue
in the experimental conditions examined.
4. Discussion
The possibility that VEGF could be produced in brown fat
cells had been suggested by Asano et al. [6], who observed
that it was expressed in the rat BAT. Until now, however,
synthesis and release of VEGF had not been demonstrated
directly as shown here for rat brown adipocytes. Among the
di¡erent VEGF isoforms that are produced by alternative
splicing in most of cells, only two (VEGF 164 and VEGF
120) were present in brown adipocytes di¡erentiated in cul-
ture, while a third isoform (VEGF 188) is expressed in enzy-
matically dispersed cells or in BAT in toto, suggesting that
brown adipocytes di¡erentiated in culture do not completely
di¡erentiate. Alternatively, a di¡erent regulation of the alter-
native splicing in cells di¡erentiated in culture or in vivo could
explain these di¡erences. The presence of VEGF protein in
cultured brown adipocytes or BAT in toto was demonstrated
by means of both Western blotting and immunohistochemis-
try.
It is known that cold exposure produces adaptive hyper-
plasia and growth of BAT that results from a rapid activation
of mitosis, not only of precursor cells of brown adipocytes,
but also of endothelial cells forming the capillaries [4]. Asano
et al. [6] have shown that when the rats were exposed to low
temperature for 1^4 h, the VEGF mRNA was increased 2^3-
fold in BAT. This increased expression of VEGF in BAT is
not surprising, because it is a tissue with a large capacity for
adaptive hypertrophy and thermogenesis, and its increase
after cold exposure could explain the intense neovascularisa-
tion in this condition. Using immunohistochemistry increased
VEGF expression was seen to occur not only in the media of
the vessels but even in brown adipocytes of animals exposed
to cold. The in vitro and in vivo (immunohistochemistry) ob-
servation that L3-adrenoceptor agonists were able to induce
markedly the expression of VEGF in brown fat cells and to
stimulate its release indicates that these e¡ects of sympathetic
activation are mediated, at least in part, by the L3-adrenocep-
tors largely expressed in these cells.
Recently, we have demonstrated that brown fat cells can
express an inducible form of nitric oxide synthase, ensuring
NO production and release. This is stimulated by sympathetic
activity in physiological conditions, and NO may represent an
important mechanism through which noradrenaline can mod-
ulate di¡erent BAT functions, in addition to vasodilatation
[18]. Since NO has been suggested to mediate the VEGF ef-
fects on endothelial cells [19], a reciprocal relationship be-
tween VEGF and NO could play a role in the regulation of
endothelial integrity. Thus, sympathetic nervous system acti-
vation could simultaneously induce vasodilatation and neo-
vascularisation through NO production and VEGF expres-
sion, ensuring an increased blood £ow to BAT. Further
studies are in progress to clarify the physiological link be-
tween VEGF and NO in brown adipocytes.
In animal models the initiation and development of genetic
obesity are due at least in part to the low level of energy
expenditure and consequent high e⁄ciency of energy utilisa-
tion. Sympathetic activity in brown fat under normal environ-
mental conditions is reduced in obese animals [20]. In adult fa/
fa rats the interscapular BAT is functionally defective as well
as its vascularisation [17,21]. Our results showed that the BAT
production of the shortest VEGF isoform is lower in obese
than in lean animals, and we have also seen that this di¡er-
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Fig. 4. RT-PCR analysis of VEGF in the BAT of obese (fa/fa) and
lean (+/fa) Zucker rats. Upper: Representative agarose gel showing
the PCR analysis for the VEGF and L-actin mRNA content; L,
DNA ladder. Lower: Densitometric analysis of RT-PCR experi-
ments is reported. The bars represent the mean values þ S.E.M. of
three separate experiments plotted in relation to the area under the
curve for the VEGF 120/VEGF 188 ratio in the BAT of lean (+/fa)
rats taken as 1. *P6 0.05 vs (+/fa) rats.
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ence increases with age (data not shown). This could explain
the defective vascularisation seen in BAT of these animals,
particularly as the shortest form of VEGF lacks heparin bind-
ing activity and is, therefore, more easily di¡usible [6]. Thus,
an impaired regulation of VEGF alternative splicing could
explain the defective BAT vascularisation in obesity.
In conclusion, our results show that VEGF is synthesised in
and released from brown adipocytes, and its production is
directly modulated by sympathetic activity, at least in part
via L3-adrenoceptors. This sympathetic modulation ensures
the supply of VEGF when functionally required and explains
its de¢cit in genetically obese animals.
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Fig. 5. Immunohistochemistry for VEGF (with a polyclonal antibody against the three isoforms, ABC method). A: BAT of a control rat kept
at 20‡C. B: BAT of a rat treated with the L3-adrenoceptor agonist CL 316,243 (1 mg/kg/day, intraperitoneally, for 2 days). The brown adipo-
cytes are intensely stained in the cytoplasm. A: 430U ; B: 1075U.
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